4.4 Review

The use of Cox-2 and PPAR gamma signaling in anti-cancer therapies

Journal

EXPERIMENTAL AND THERAPEUTIC MEDICINE
Volume 1, Issue 2, Pages 257-264

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/etm_00000040

Keywords

cyclooxygenase-2; peroxisome proliferator-activated receptor gamma; prostaglandins; nonsteroidal anti-inflammatory drugs

Funding

  1. Czech Science Foundation [301/09/1115, 204/08/H054]
  2. Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622415]
  3. Masaryk University [MUNI/0099/2009]

Ask authors/readers for more resources

Increased production of the pro-inflammatory enzyme cyclooxygenase-2 (Cox-2) and altered expression and activity of peroxisome proliferator-activated receptor gamma (PPAR gamma) have been observed in many malignancies. Both the PPAR gamma ligands and the Cox-2 inhibitors possess anti-inflammatory and anti-neoplastic effects in vitro and have been assessed for their therapeutic potential in several pre-clinical and clinical studies., Recently, multiple interactions between PPAR gamma and Cox-2 signaling pathways have been revealed. Understanding of the cross-talk between PPAR gamma and Cox-2 might provide important novel strategies for the effective treatment and/or prevention of cancer. This article summarizes recent achievements involving the functional interactions between the PPAR gamma and Cox-2 signaling pathways and discusses the implications of such interplay for clinical use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Osteogenic Potential of the Transcription Factor c-MYB

V. Oralova, E. Matalova, M. Killinger, L. Knopfova, J. Smarda, M. Buchtova

CALCIFIED TISSUE INTERNATIONAL (2017)

Article Nutrition & Dietetics

Dietary fatty acids specifically modulate phospholipid pattern in colon cells with distinct differentiation capacities

Jirina Hofmanova, Josef Slavik, Petra Ovesna, Zuzana Tylichova, Jan Vondracek, Nicol Strakova, Alena Hyrslova Vaculova, Miroslav Ciganek, Alois Kozubik, Lucie Knopfova, Jan Smarda, Miroslav Machala

EUROPEAN JOURNAL OF NUTRITION (2017)

Article Endocrinology & Metabolism

Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction

Katarina Chalasova, Lukas Pacal, Anna Pleskacova, Lucia Knopfova, Jitka Rehorova, Marie Tomandlova, Josef Tomandl, Katerina Kankova

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2018)

Article Biochemistry & Molecular Biology

Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding

L. Knopfova, E. Biglieri, N. Volodko, M. Masarik, M. Hermanova, J. F. Glaus Garzon, M. Ducka, T. Kucirkova, K. Soucek, J. Smarda, P. Benes, L. Borsig

ONCOGENE (2018)

Article Oncology

Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition

Jan Remsik, Lucia Bino, Zuzana Kahounova, Gvantsa Kharaishvili, Sarka Simeckova, Radek Fedr, Tereza Kucirkova, Sara Lenart, Ximena Maria Muresan, Eva Slabakova, Lucia Knopfova, Jan Bouchal, Milan Kral, Petr Benes, Karel Soucek

CARCINOGENESIS (2018)

Article Oncology

CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis

Marko Roblek, Darya Protsyuk, Paul F. Becker, Cristina Stefanescu, Christian Gorzelanny, Jesus F. Glaus Garzon, Lucia Knopfova, Mathias Heikenwalder, Bruno Luckow, Stefan W. Schneider, Lubor Borsig

MOLECULAR CANCER RESEARCH (2019)

Article Physiology

Two Types of High Inductive Electromagnetic Stimulation and Their Different Effects on Endothelial Cells

J. Prucha, J. Skopalik, V Socha, L. Hanakova, L. Knopfova, K. Hana

PHYSIOLOGICAL RESEARCH (2019)

Article Biochemical Research Methods

Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis

Jakub Faktor, Lucia Knopfova, Petr Lapcik, Lucia Janacova, Vendula Paralova, Pavla Bouchalova, Petr Mueller, Petr Benes, Pavel Bouchal

PROTEOMICS (2019)

Article Multidisciplinary Sciences

Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors

Nataliya Volodko, Taras Gutor, Orest Petronchak, Roman Huley, Monika Ducka, Jan Smarda, Lubor Borsig, Petr Benes, Lucia Knopfova

SCIENTIFIC REPORTS (2019)

Article Biochemistry & Molecular Biology

Large-Scale Automated Hollow-Fiber Bioreactor Expansion of Umbilical Cord-Derived Human Mesenchymal Stromal Cells for Neurological Disorders

Ladislava Vymetalova, Tereza Kucirkova, Lucia Knopfova, Veronika Pospisilova, Tomas Kasko, Hana Lejdarova, Eva Makaturova, Petr Kuglik, Veronika Oralova, Eva Matalova, Petr Benes, Zdenek Koristek, Serhiy Forostyak

NEUROCHEMICAL RESEARCH (2020)

Article Chemistry, Analytical

Ozonization of Tissue Sections for MALDI MS Imaging of Carbon-Carbon Double Bond Positional Isomers of Phospholipids

Antonin Bednarik, Jan Preisler, Dominika Bezdekova, Marketa Machalkova, Michal Hendrych, Jarmila Navratilova, Lucia Knopfova, Eugene Moskovets, Jens Soltwisch, Klaus Dreisewerd

ANALYTICAL CHEMISTRY (2020)

Article Oncology

c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells

Monika Ducka, Martina Kucerikova, Filip Trcka, Jakub Cervinka, Elisabetta Biglieri, Jan Smarda, Lubor Borsig, Petr Benes, Lucia Knopfova

Summary: c-Myb is involved in the activation of genes with protumorigenic function, and its interaction with IL1 alpha and NF-kappa B signaling axis in tumor cells plays a critical role in regulating metastasis and inflammatory genes in breast cancer. This pathway presents a potential target for therapeutic interventions to mimic the antimetastatic effect of c-Myb.

NEOPLASIA (2021)

Article Oncology

Transcription factor c-Myb: novel prognostic factor in osteosarcoma

Kamila Rihova, Monika Ducka, Iva Staniczkova Zambo, Ladislava Vymetalova, Martin Sramek, Filip Trcka, Jan Verner, Stanislav Drapela, Radek Fedr, Tereza Suchankova, Barbora Pavlatovska, Eva Ondrouskova, Irena Kubelkova, Danica Zapletalova, Stepan Tucek, Peter Mudry, Dagmar Adamkova Krakorova, Lucia Knopfova, Jan Smarda, Karel Soucek, Lubor Borsig, Petr Benes

Summary: c-Myb is a negative prognostic factor in osteosarcoma, involved in regulating cell growth, chemosensitivity, migration, and metastatic activity in osteosarcoma cells.

CLINICAL & EXPERIMENTAL METASTASIS (2022)

Article Oncology

Tumor Cell-Intrinsic c-Myb Upregulation Stimulates Antitumor Immunity in a Murine Colorectal Cancer Model

Merel van Gogh, Jesus F. Glaus Garzon, Dilara Sahin, Lucia Knopfova, Petr Benes, Onur Boyman, Igor Jurisica, Lubor Borsig

Summary: The authors demonstrate that c-Myb expression in tumor cells induces the expression of immune-related genes, leading to immunomodulation and inhibition of tumor growth.

CANCER IMMUNOLOGY RESEARCH (2023)

Article Oncology

High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma

Michal Tichy, Lucia Knopfova, Jiri Jarkovsky, Petr Vlcek, Jana Katolicka, Ivan Capov, Marketa Hermanova, Jan Smarda, Petr Benes

JOURNAL OF CANCER (2019)

No Data Available